Tumoral Endoglin (CD105) Regulates the Tumor Microenvironment, Tumorigenicity and Therapeutic Response in Renal Cell Carcinoma

被引：0
|
作者：
Oladejo, M. [1 ]
Wood, L. M. [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Abilene, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2465
引用
收藏
页码：E208 / E208
页数：1
相关论文
共 50 条
  • [21] Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
    Ester Fonsatti
    Maresa Altomonte
    Maria Rita Nicotra
    Pier Giorgio Natali
    Michele Maio
    Oncogene, 2003, 22 : 6557 - 6563
  • [22] Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
    Fonsatti, E
    Altomonte, M
    Nicotra, MR
    Natali, PG
    Maio, M
    ONCOGENE, 2003, 22 (42) : 6557 - 6563
  • [23] Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
    Claudia Ollauri-Ibáñez
    Elena Núñez-Gómez
    Cristina Egido-Turrión
    Laura Silva-Sousa
    Elena Díaz-Rodríguez
    Alicia Rodríguez-Barbero
    José M. López-Novoa
    Miguel Pericacho
    Angiogenesis, 2020, 23 : 231 - 247
  • [24] Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
    Ollauri-Ibanez, Claudia
    Nunez-Gomez, Elena
    Egido-Turrion, Cristina
    Silva-Sousa, Laura
    Diaz-Rodriguez, Elena
    Rodriguez-Barbero, Alicia
    Lopez-Novoa, Jose M.
    Pericacho, Miguel
    ANGIOGENESIS, 2020, 23 (02) : 231 - 247
  • [25] Endoglin (CD105) in AML: A Potential Novel Target for Therapeutic Intervention
    Dourado, Keina M. Campos
    Vanessa, Perinazzo-Oliveira
    Baik, June
    Beltrame, Miriam P.
    Verneris, Michael R.
    Theuer, Charles
    Perlingeiro, Rita C. R.
    BLOOD, 2016, 128 (22)
  • [26] Endoglin (CD105): A marker of tumor vasculature and potential target for therapy
    Dallas, Nikolaos A.
    Samuel, Shaija
    Xia, Ling
    Fan, Fan
    Gray, Michael J.
    Lim, Sherry J.
    Ellis, Lee M.
    CLINICAL CANCER RESEARCH, 2008, 14 (07) : 1931 - 1937
  • [27] CD105 as a tool for assessing microvessel density in renal cell carcinoma
    Cioca, Andreea
    Muntean, Diana
    Bungardean, Catalina
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2019, 62 (02) : 239 - 243
  • [28] Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
    Hu, Junhui
    Guan, Wei
    Yan, Libin
    Ye, Zhangqun
    Wu, Lily
    Xu, Hua
    STEM CELLS INTERNATIONAL, 2019, 2019
  • [29] Evaluation of endoglin/CD105 as a tumor vasculature target with antibody drug conjugates
    Wu, Rui
    Gavrilescu, Cristina
    Liu, Yimao
    Santos, Valerie Chamberlain
    Lai, Katharine C.
    Harris, Luke
    Shah, Prerak
    Donahue, Kerry
    Chari, Ravi
    Gregory, Richard
    Chittenden, Thomas
    Guidi, Cynthia
    Keating, Thomas A.
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma
    Yagmur, Eray
    Rizk, Mohamed
    Stanzel, Sven
    Hellerbrand, Claus
    Lammert, Frank
    Trautwein, Christian
    Wasmuth, Hermann E.
    Gressner, Axel M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (09) : 755 - 761
12345